R&D MA Granted in Germany

You are here

Lyon, 22 September 2016  Amoéba has announced today that it has been granted a marketing authorisation for research and development for 10 industrial sites in Germany. The authorisation was issued by the German Federal Institute for Occupational Safety and Health that is one of the strictest authorities in Europe in the field of environmental and occupational protection. Thanks to the new studies and tests carried out by Amoéba since obtaining the R&D authorisation in France, the German authority has issued an unrestricted marketing authorisation allowing the discharge of the product into the environment. On the whole, more than 20 industrial sites have tested or are currently testing the biological biocide BIOMEBA across Europe covering a wide range of sectors. All studies conducted by our teams since 2010 have allowed us to establish the safety and effectiveness of BIOMEBA which have greatly contributed to obtaining this approval. This application for R&D a few months away from the provisional marketing authorisation application also allows us to build a relationship with the German regulatory authorities in order to understand their approach.”, stated Fabrice Plasson, President of AMOEBA’s Board of Directors.

Related Posts